Better understanding of the different mutations that drive GIST is leading to new paradigms of tailored treatment that break many norms of chemotherapy, especially in management of progression.
Related Articles
Grandround
Managing common toxicities with new tyrosine kinase inhibitors
Systems & Services
Europe’s rare cancer community calls for a more radical approach
Senza categoria
Leave a Reply